Tyra Biosciences, Inc. (TYRA) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
TYRA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TYRA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export TYRA earnings history in CSV or JSON format
Free sign-in required to download data
Tyra Biosciences, Inc. (TYRA) Earnings Overview
As of May 8, 2026, Tyra Biosciences, Inc. (TYRA) reported trailing twelve-month net income of -$120M, reflecting -33.1% year-over-year growth. The company earned $-2.01 per diluted share over the past four quarters.
Looking at the long-term picture, TYRA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2019.
Tyra Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KROS ($87M net income, 35.7% margin), NUVL (-$450M net income), PRAX (-$327M net income), TYRA has comparable earnings metrics. Compare TYRA vs KROS →
TYRA Earnings vs Peers
Earnings metrics vs comparable public companies
TYRA Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$120M | -38.7% | -$133M | $-2.01 | - | - |
| 2024 | -$86M | -25.1% | -$104M | $-1.51 | - | - |
| 2023 | -$69M | -25.0% | -$80M | $-1.62 | - | - |
| 2022 | -$55M | -110.4% | -$59M | $-1.23 | - | - |
| 2021 | -$26M | -182.3% | -$26M | $-0.63 | - | - |
| 2020 | -$9M | -129.5% | -$9M | $-0.22 | - | - |
| 2019 | -$4M | - | -$3M | $-0.10 | - | - |
See TYRA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TYRA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TYRA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTYRA — Frequently Asked Questions
Quick answers to the most common questions about buying TYRA stock.
Is TYRA growing earnings?
TYRA EPS fell to $-2.01, with earnings declining -33.1%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-120M.
What are TYRA's profit margins?
Tyra Biosciences, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are TYRA's earnings?
TYRA earnings data spans 2019-2025. The declining earnings trend is -33.1% YoY. Historical data enables comparison across business cycles.